Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 741-755
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.741
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.741
Figure 6 In patients with gastric cancer, the immunohistochemical expression of Maspin (0-negative; c-cytoplasm expression; m-mixed expression; N-nuclear positivity) and p53 (0-negative; 1-below 50%; 2-over 50%) does not have independent prognostic value, but wild-type TP53 cases (W) have a slightly longer survival time.
- Citation: Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, Iwashita Y, Szodorai R, Szederjesi J. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol 2020; 12(7): 741-755
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/741.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.741